Statin reduce the platelet P-selectin expression in atherosclerotic ischemic stroke

Journal of Thrombosis and Thrombolysis

Volumn 18, Issue 1, 2004, Pages 39-42

  Cha, Jae Kwan ^a   Jeong, Min Ho ^a   Kim, Jae Woo ^a  

^a Dong A University   (South Korea)

Author keywords

Platelet; Statin; Thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PADGEM PROTEIN;

ADD ON THERAPY; ADULT; ARTICLE; BRAIN ATHEROSCLEROSIS; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; DRUG WITHDRAWAL; FATIGUE; FEMALE; FLOW CYTOMETRY; HUMAN; LIBIDO DISORDER; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STATISTICAL ANALYSIS; THROMBOCYTE; THROMBOGENESIS; AGED; ARTERIOSCLEROSIS; BIOSYNTHESIS; BLOOD; BRAIN ISCHEMIA; CLINICAL TRIAL; COMPARATIVE STUDY; DRUG EFFECT; GENE EXPRESSION REGULATION; MIDDLE AGED; PHYSIOLOGY; PROSPECTIVE STUDY;

AGED; ARTERIOSCLEROSIS; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; FEMALE; GENE EXPRESSION REGULATION; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; P-SELECTIN; PROSPECTIVE STUDIES;

EID: 14944343554     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11239-004-0172-1     Document Type: Article

References (28)

1. Neumann F-J, Marx N, Gawaz M, et al. Induction of cytokine expression in leukocytes by binding of thrombin-stimulated platelets. Circulation 1997;95:2387-2394.
2. Gawaz M, Neumann F-J, Dickfeld T, et al. Activated platelets induce monocyte chemotactic protein-1 secretion and surface expression of intercellular adhesion molecule-1 on endothelial cells. Circulation 1998;98:1164-1171.
3. Manka D, Collins RG, Ley K, et al. Absence of p-selectin, but not intercellular adhesion molecule-1, attenuates neointimal growth after arterial injury in apolipoprotein e-deficient mice. Circulation 2001;103:1000-1005.
4. Dong ZM, Brown AA, Wagner DD. Prominent role of P-selectin in the development of advanced atherosclerosis in ApoE-deficient mice. Circulation 2000;101:2290-2295.
5. Gurbel PA, O'Connor CM, Dalesandro MR, et al. Relation of soluble and platelet P-selectin to early outcome in patients with acute myocardial infarction after thrombolytic therapy. Am J Cardiol 2001;87:774-777.
6. Cha J-K, Jeong M-H, Kim E-K, et al. Surface expression of p-selectin on platelets is related with clinical worsening in acute ischemic stroke. J Kor Med Sci 2002;17:811-816.
7. Libby P, Aikawa M. Mechanisms of plaque stabilization with statins. Am J Cardiol 2003;91:4B-8B.
8. Bonetti PO, Lerman LO, Napoli C, et al. Statin effects beyond lipid lowering-are they clinically relevant? Eur Heart J 2003;24:225-248.
9. Veillard NR, Mach F. Statins: The new aspirin? Cell Mol Life Sci 2002;59:1771-1786.
10. Hankey GJ. Role of lipid-modifying therapy in the prevention of initial and recurrent stroke. Curr Opin Lipidol 2002;13:645-651.
11. Huhle G, Abletshauser C, Mayer N, et al. Reduction of platelet activity markers in type II hypercholesterolemic patients by a HMG-CoA-reductase inhibitor. Thromb Res 1999;95:229-234.
12. Adams HP Jr, Bendixen BH, Kappelle LJ, et al. 3rd. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993;24:35-41.
13. Serebruany VL, Cummings CC, Malinin AI, et al. Uniform platelet activation exists before coronary stent implantation despite aspirin therapy. Am Heart J 2001;142:611-616.
14. Nomura S, Kanazawa S, Fukuhara S. Effects of efonidipine on platelet and monocyte activation markers in hypertensive patients with and without diabetes mellitus. J Hum Hypertens 2002;16:539-547.
15. Cha JK, Jeong MH, Lee KM, et al. Changes in platelet P-selectin and in plasma C-reactive protein in acute atherosclerotic ischemic stroke treated with a loading dose of clopidogrel. J Thromb and Thrombolysis 2002;14:145-150.
16. Gawaz M. Evaluation of platelet membrane glycoproteins in coronary artery disease. Circulation 1999;99:1-11.
17. Zeller JA, Tschoepe D, Kessler C. Circulating platelets shows increased activation in patients with acute cerebral ischemia. Thromb Haemost 1999;81:373-377.
18. Yamazaki M, Uchiyama S, Iwata M. Measurement of platelet fibrinogen biding and P-selectin expression by flow cytometry in patients with cerebral infarction. Thromb Res 2001;104:197-205.
19. Kent SM, Flaherty PJ, Coyle LC, et al. Effect of atorvastatin and pravastatin on serum C-reactive protein. Am Heart J 2003;145:e8.
20. Bickel C, Rupprecht HJ, Blankenberg S, et al. Influence of HMG-CoA reductase inhibitors on markers of coagulation, systemic inflammation and soluble cell adhesion. Int J Cardiol 2002;82:25-31.
21. Gertz K, Laufs U, Lindauer U, et al. Withdrawal of statin treatment abrogates stroke protection in mice. Stroke 2003;34:551-557.
22. Puddu P, Puddu GM, Muscari A. HMG-CoA reductase inhibitors: Is the endothelium the main target? Cardiology 2001;95:9-13.
23. Cipollone F, Mezzetti A, Porreca E, et al. Association between enhanced soluble CD40L and prothrombotic state in hypercholesterolemia: Effects of statin therapy. Circulation 2002;23;106:399-402.
24. Osamah H, Mira R, Sorina S, et al. Reduced platelet aggregation after fluvastatin therapy is associated with altered platelet lipid composition and drug binding to the platelets. Br J Clin Pharmacol 1997;44:77-83.
25. Srivastra R, Srimal RC. Amplification of platlete response during acute inflammation in Rats. Biochem Pharmacol 1990;40:357-363.
26. Neumann F-J, Marx N, Gawaz M, et al. Induction of cytokine expression in leukocytes by binding of thrombin-stimulated platelets. Circulation 1997;95:2387-2394.
27. Ridker PM. CRP and the risks of future myocardial infarction and thrombotic stroke. Eur Heart J 1998;19:1-3.
28. Zhao L, Bath P, Heptinstall S. Effects of combining three different anti-platelet agents on platelets and leukocytes in whole blood in vitro. Br J Pharmacol 2001;134:353-358.